Other highlights in the June 5 issue of JNCI

June 04, 2002

Cancer Registries Provide Information on Quality of Cancer Care
Data from cancer registries may, in some cases, be more accurate than data from patient medical records, suggesting that registries could be a good resource for collecting data on the quality of cancer care. The findings appear in the June 5 issue of the Journal of the National Cancer Institute.

Various groups have called for a national system to monitor the quality of cancer care. However, the validity of cancer registry data has not yet been proven. In this study, Jennifer L Malin, M.D., of the Jonsson Comprehensive Center at the University of California at Los Angeles, and her colleagues compared registry data regarding cancer care with medical records from 304 breast cancer patients.

Malin and her colleagues found that the accuracy of registry data was higher for hospital-based services such as mastectomy and lymph node dissection than for ambulatory services such as biopsy and chemotherapy. The authors conclude that registries could provide the infrastructure for collecting data on the quality of cancer care; they recommend that funding be increased to support data collection by cancer registries.

Blocking Growth Factor Receptor Prevents Local But Not Distant Metastases
Blocking signaling by the vascular endothelial growth factor receptor-3 (VEGFR-3), which stimulates tumor lymphogianesis (the formation of lymphatic vessels), can suppress regional metastasis to the lymph nodes, a new study suggests. The findings were published in the June 5 issue of the Journal of the National Cancer Institute.

Kari Alitalo, Ph.D., of the University of Helsinki in Finland, and her colleagues used a receptor-antibody fusion protein to block two vascular endothelial growth factors (VEGF-C and VEGF-D) that induce angiogenesis and lymphangiogensesis in tumors via VEGFR-3 signaling.

The authors found that blocking VEGFR-3 signaling suppressed primary tumor and regional lymph node metastasis but had no effect on distant lung metastasis. Moreover, they found that overexpression of VEGF-C did not increase the incidence of lymph node metastasis. These findings suggest that lymph node metastasis is regulated by additional factors besides VEGF-C and that its inhibition may not block distant organ metastasis.

Computer Model, Risk Counselors Identify Likely BRCA Mutation Carriers
A new study suggests that cancer risk counselors and computer models have similar sensitivity when it comes to identifying women likely to carry BRCA gene mutations. The findings appear in the June 5 issue of the Journal of the National Cancer Institute.

Genetic testing can be costly and sometimes they clinical relevance of the results can be ambiguous. Therefore, people considering testing must first receive pretest counseling to determine their likelihood of carrying a genetic mutation. Pretest counseling is traditionally done by cancer risk counselors; however, more recently, a computer model has been developed for this purpose.

In this study, David M. Euhus, M.D., of the University of Texas Southwestern Medical Center, and his coworkers compared the performance of eight cancer risk counselors with that the computer model, BRCAPRO at identifying families likely to carry a BRCA mutation. The sensitivity (ability to identify mutation carriers) of both the risk counselors and BRCAPRO was greater than 90%. However, BRCAPRO consistently demonstrated greater specificity (ability to rule out mutation non-carriers) than the risk counselors.

Genetic Changes in Benign Breast Tissue May Indicate Increased Risk of Breast Cancer
A genetic change called loss of heterozygosity (LOH) in benign breast epithelial cells may be an early step in the process of breast cancer carcinogenesis, a new study concludes. In the future, this molecular analysis could be used to determine a woman's risk for breast cancer, the authors conclude in the June 5 issue of the Journal of the National Cancer Institute.

DNA alterations such as structural rearrangement of chromosomes and changes in chromosome copy number are known to be present in breast cancer cells. These genetic changes result in genomic instability. David M. Euhus, M.D., and colleagues from the University of Texas Southwestern Medical Center at Dallas, investigated whether LOH--the deletion of chromosomal material during DNA replication or repair--was associated with abnormal cytology in the breast and a woman's overall risk of breast cancer.

The investigators measured LOH in breast epithelial cells obtained by random fine needle aspiration (FNA) biopsy from 30 asymptomatic women whose risk of breast cancer had been estimated by the Gail model. LOH was detected in two of 11 women with normal cytology and in 14 of 19 women with abnormal cytology. The mean lifetime risk for developing breast cancer, calculated using the Gail model, was 16.7% for women with no LOH compared with 22.9% for women with LOH.

The authors conclude that the identification of LOH in benign breast epithelium obtained by random FNA is strongly associated with cytologic features of typical and atypical proliferation and is nominally associated with calculated breast cancer risk level.
Attribution to the Journal of the National Cancer Institute is requested in all news coverage.

Journal of the National Cancer Institute

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.